Net profit of Tatva Chintan Pharma Chem declined 45.16% to Rs 5.21 crore in the quarter ended June 2024 as against Rs 9.50 crore during the previous quarter ended June 2023. Sales declined 7.78% to Rs 105.46 crore in the quarter ended June 2024 as against Rs 114.36 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 105.46 | 114.36 | -8 |
| OPM % | 11.97 | 18.66 | - |
| PBDT | 13.47 | 19.43 | -31 |
| PBT | 6.81 | 13.42 | -49 |
| NP | 5.21 | 9.50 | -45 |